Why the study?
Diagnostic criteria for Type 2 myocardial infarction identify a heterogeneous population with variable outcomes and unclear treatment implications, prompting evaluation of a new classification with more objective imaging criteria.
Does a new clinical classification of myocardial infarction using systematic cardiac imaging improve risk stratification and prognostic prediction of death, recurrent myocardial infarction, or heart failure hospitalization in patients diagnosed with Type 2 myocardial infarction?
Does a new clinical classification of myocardial infarction using systematic cardiac imaging improve risk stratification and prognostic prediction of death, recurrent myocardial infarction, or heart failure hospitalization in patients diagnosed with Type 2 myocardial infarction?
Answers are grounded in this paper and cite their sources.
Applying an imaging-informed clinical classification to patients diagnosed with Type 2 myocardial infarction excludes myocardial infarction in nearly half of cases while identifying a high-risk subgroup with secondary myocardial infarction who experience a 55% rate of death, recurrent MI, or heart failure hospitalization over 4.4 years.
AIMS: The diagnostic criteria for Type 2 myocardial infarction identify a heterogeneous group of patients with variable outcomes and no clear treatment implications. We aimed to determine the implications of a new clinical classification for myocardial infarction with more objective diagnostic criteria using cardiac imaging. METHODS AND RESULTS: In a prospective cohort study, patients with Type 2 myocardial infarction underwent coronary angiography and cardiac magnetic resonance imaging or echocardiography. The new classification was applied to identify (i) spontaneous myocardial infarction due to acute coronary pathology, (ii) secondary myocardial infarction precipitated by acute illness in the presence of obstructive coronary artery disease, a new regional wall motion abnormality, or infarct-pattern scarring, and (iii) no myocardial infarction in the absence of obstructive disease or new myocardial abnormality. In 100 patients (65 years, 43% women) with Type 2 myocardial infarction, the new classification identified 25 and 31 patients with spontaneous and secondary myocardial infarction, respectively, and 44 without myocardial infarction. Compared with patients without myocardial infarction, those with secondary myocardial infarction were older, had more risk factors, and had higher troponin concentrations (P < 0.05 for all). During a median follow-up of 4.4 years, death, myocardial infarction, or heart failure hospitalization was more common in secondary myocardial infarction compared with those without myocardial infarction [55% (17/31) vs. 16% (7/44), P < 0.001]. CONCLUSION: A new clinical classification of myocardial infarction informed by cardiac imaging would reduce the diagnosis of myocardial infarction in acute illness and identify those patients at highest risk who are most likely to benefit from treatment. CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT03338504.
No takes yet. Share an insight, caveat, or question.
Boeddinghaus et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: